Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, known as steatotic liver diseases, contribute to the de...
Read moreEl uso de transferencia de embriones congelados se asocia con un mayor tamaño fetal desde las primeras semanas
Read moreMenstruation may act as a cofactor that increases the severity of food allergic reactions in some women. Although this phenomenon remains poorly understood and is likely underdiagnosed, research sugge...
Read moreUn equipo liderado desde la UAM ha adaptado y validado al español el cuestionario ASC-12, una herramienta breve y autoadministrada que permite evaluar la alodinia cutánea en pacientes con cefaleas p...
Read moreEl programa cubre en profundidad: las bases moleculares de la carcinogénesis, proto-oncogenes y oncogenes, genes supresores de tumores, técnicas de patología molecular, patología molecular aplicad...
Read moreChanging CDMO late in development is not always a warning sign. Sometimes it is the right decision. But it should be managed as a strategic move, not an administrative transfer.
Read moreHCP monitoring in biopharmaceutical manufacturing is classified as a critical quality attribute in regulatory guidance and not merely a characterization exercise.
Read moreThe study analyses the role of PARP2 protein in tumour development and protection, and describes how its elimination leads to tumour cell death and activation of the immune system
Read moreResearchers from ICO and IDIBELL have developed a simple model based on health questionnaires that could help identify people who are more likely to suffer from the disease before symptoms appear.
Read moreThe event brought together professionals from research, healthcare, entrepreneurship and investment, with the presentation of the 15 projects taking part in the new edition of GrowInn and recognition ...
Read moreSi quieres descubrir todo lo que pueden aportar sensores inteligentes al sector del deporte y de la salud, no te pierdas esta jornada en la que presentaremos resultados disruptivos que te sorprenderá...
Read moreNew preliminary data presented at EHA 2026 highlight the potential of OC-1 in a rare and aggressive blood cancer with limited treatment options.
Read more